Global Research PartnershipsCreate free account
Industry Collaboration Index

Industry Collaboration Index 2026 · University profile

Guangzhou Medical University

China · Asia-Pacific · Silver

#577World rank of 1,038
46.4ICI scoreout of 100
#81National rank, of 169 in China
#169Regional rank, of 343 in Asia-Pacific
658.5Verified industry works, 2021 to 2025
282Company groups worked with (99 on two or more works)

Guangzhou Medical University is ranked #577 of 1,038, with Silver standing. Its strongest pillar is durability (74): 32 of its company groups are sustained partners (five or more joint works in three or more of the five years). It is held back most by co-creation (19): 658.5 verified industry works against about 1,169 expected for its mix of fields; and by breadth (35): partners concentrated in a few research fields.

Research Collaboration Index 2026: #647 of 1,195 · View the RCI profile →

Why this position

Four pillars, as percentiles

Co-creation30% of the score
19

How often it co-authors with companies, compared with what its own mix of research fields would predict; size makes no difference. 658.5 verified works against about 1,169 expected for its fields (0.56 times the expected rate).

Durability20% of the score
74

How much of its industry work sits in sustained partnerships with the same company group. 32 sustained partnerships: five or more joint works in three or more of the five years.

Scale30% of the score
63

The size of its industry network: company groups on two or more works, sustained partnerships, and its place in the worldwide network of universities and companies. 99 company groups on two or more joint works; 32 sustained partnerships.

Breadth20% of the score
35

How varied its partners are, judged by each company's main research field. Measured across the main research fields of all the company groups it worked with.

Each pillar is a percentile among the 1,038 ranked universities: a value of 80 means a higher value than about 80 in every 100 of them. The ICI score (46.4) is the weighted average of the four percentiles. Rank 577 of 1,038 overall; 81 of 169 in China; 169 of 343 in Asia-Pacific. Standing bands: Platinum for ranks 1 to 100, Gold 101 to 300, Silver 301 to 600. How the index is built →

In numbers

The evidence behind the position

2.7%of its 24,441 research works in 2021 to 2025 were co-authored with a verified company
0.56Industry co-authorship rate: 0.56 times what its mix of research fields would predict (658.5 verified works; about 1,169 expected)
32sustained partnerships: the same company group on five or more joint works in three or more of the five years

In China

81 of 169 ranked universities in China

  1. #79 Ocean University of China world #567, score 46.8
  2. #80 Northwest University world #568, score 46.7
  3. #81 Guangzhou Medical University world #577, score 46.4
  4. #82 Shandong First Medical University world #585, score 46.0
  5. #83 Renmin University of China world #590, score 45.7

All ranked universities →   Asia-Pacific: 169 of 343 →

Where it works with industry

Sector strengths

Verified industry works by sector, with its position in each sector ranking. A university is ranked in a sector once it has at least 20 verified works there; sectors with fewer than 50 eligible universities are provisional.

Strongest sector positions

#168 of 638Pharmaceuticals and Therapeutics183.5 verified works in the sector
#98 of 220Biotechnology and Advanced Therapies42.5 verified works in the sector
Pharmaceuticals and Therapeutics
183.5#168 of 638
Biotechnology and Advanced Therapies
42.5#98 of 220
Medical Technology and Digital Health
32#203 of 323
Artificial Intelligence
17.5under 20 works
Climate, Environment and Sustainability
5.5under 20 works
Advanced Materials and Nanotechnology
3under 20 works
Agriculture and Food Technology
3under 20 works
Chemicals, Process and Resources
2under 20 works
Robotics and Autonomous Systems
1ranking withheld (under 10 eligible)
Not in any of the 21 sectors
368counted in the overall index

290.5 of its 658.5 verified industry works fall within the 21 sectors. The rest have research topics that belong to no industry sector (basic science, for example) or are consortium papers with 100 or more authors, which the sector indices leave out; all of them count fully in the overall index.

Who it works with

Company partners, 2021 to 2025

Guangzhou Medical University co-authored verified work with 282 company groups, consortium papers aside: 99 of them on two or more works, and 32 as sustained partners.

The largest 12 of its 282 company groups, by joint works

Company groupBased inCompany's main research fieldJoint worksYears with a joint work
BGI GroupChinaBiochemistry, Genetics and Molecular Biology64.55 of 5
Jiangsu Hengrui MedicineChinaMedicine335 of 5
AstraZenecaUnited KingdomMedicine21.54 of 5
PhilipsNetherlandsEngineering215 of 5
Guangzhou Electronic TechnologyChinaEngineering164 of 5
Burning Rock BiotechChinaMedicine15.55 of 5
GlaxoSmithKlineUnited KingdomMedicine135 of 5
Qilu Pharmaceutical Co.ChinaMedicine134 of 5
GenecastChinaMedicine125 of 5
NeusoftChinaComputer Science123 of 5
Vision MedicalsChinaMedicine115 of 5

1 further partner group is not named here because the open record gives an address, a person's name or other text in place of an organisation's name; its joint works still count in every figure on this page.

A company group brings together a company's subsidiaries and research labs under one name. A work counts half when its only company author also holds a post at this university. Consortium papers with 100 or more authors are left out of this table.

Examples of its work with industry

Most-cited verified joint works

Its most-cited verified works with 30 or fewer authors, leaving out guidelines and consensus statements. Citation counts are those of the open scholarly record at harvest. Each title links to the work.

Over time

Verified industry works by year

109.52021
112.52022
1192023
148.52024
1692025

2025 is not yet complete: papers published late in the year are still being added to the open record, and coverage may not be equally complete for every university, so compare years with care. A work counts half when its only company author also holds a post at the university, so some totals end in .5.

Clinical trials (reported, not scored)

14 industry-partnered clinical trials

Trials starting 2021 to 2025 in ClinicalTrials.gov in which a company and this university are the sponsor and a collaborator. Names are matched exactly, so a trial registered only under an affiliated hospital's own name is not counted here, and the count can be well below the university's real trial activity. Trials do not enter the score.

Examples:

  • NCT07150416 Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study with Shenzhen SiBiono GeneTech Co.,Ltd, 2025
  • NCT07153744 Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction with Shanghai Hutchison Pharmaceuticals Limited, 2025
  • NCT06702098 Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia with Guangzhou Ruixin Biotechnological Co., LTD, 2024
  • NCT07232784 Serial Measurement of Pancreatic Stone Protein (PSP) for Sepsis Early Detection in ICU Patients with Fapon Biotech Inc., 2024
  • NCT06518655 Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath with ChromX Health, 2024
  • NCT06528418 Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath with ChromX Health, 2024

Evidence checked

902 verified company links

Each counted link (one work, this university and one company) was confirmed against the affiliation text its author wrote; 636 of 1,538 candidate links were set aside.

Why links were set aside
  • 356 company name not written in the author's affiliation
  • 73 ordinary-word name without a company suffix
  • 54 part of a university or public institute's own unit
  • 30 not an industry organisation
  • 29 a place or common word that failed its stricter rule
  • 22 excluded after hand audit: Matched from the Vanke School of Public Health and a street address
  • 72 for other reasons: smaller hand-audit findings, and links the current open record no longer supports

If a partner is missing or should not be here, send the evidence; corrections are free and reviewed against the public record.

For your communications

Badges you can use

Silver standing badge

Use the badge with a link to this page.

GRP Partnership Intelligence Platform

Where Guangzhou Medical University's collaboration could go next

This profile is free and public, and it stays that way. Beyond it, the GRP Partnership Intelligence Platform, a partner service arranged with each university, sets your record in both GRP indices beside the peers you choose: the universities and companies your peers work with that you do not, live funding calls matched to your strengths, the EU projects your peers have won, and a brief ready for your executive. It opens to partner universities on Monday 19 October 2026: enquire, and the GRP team will confirm availability and pricing for your university.

Request first access →  See what is inside →

The platform cannot move any university's position, band or score.

The other GRP index

Research Collaboration Index

In the Research Collaboration Index 2026, Guangzhou Medical University ranks #647 of 1,195. It measures the whole research network, not only industry.

View the RCI profile →

Something wrong? Every figure comes from the public record and can be checked. If a partner is missing or should not be there, tell us and we will review it with the evidence. The 2027 edition will be calculated with the same published methodology. The window for universities to submit data for it is open now: submit data for the 2027 edition. The index is free, public and independent. No commercial relationship with any university or company changes any position, and no one can pay to be included, excluded or moved.